Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 1, Pages e51805
Publisher
Public Library of Science (PLoS)
Online
2013-01-12
DOI
10.1371/journal.pone.0051805
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
- (2010) Knut Liseth et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
- (2010) Rupal Ramakrishnan et al. JOURNAL OF CLINICAL INVESTIGATION
- Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
- (2010) Nichole L. Bryant et al. JOURNAL OF NEURO-ONCOLOGY
- Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms
- (2010) Zvi G Fridlender et al. MOLECULAR THERAPY
- Acquired Resistance to Temozolomide in Glioma Cell Lines: Molecular Mechanisms and Potential Translational Applications
- (2010) Jihong Zhang et al. ONCOLOGY
- U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
- (2010) Michael James Clark et al. PLoS Genetics
- Engineered drug-resistant immunocompetent cells enhance tumor cell killing during a chemotherapy challenge
- (2009) Anindya Dasgupta et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- γδ T cells as immune effectors against high-grade gliomas
- (2009) Lawrence S. Lamb IMMUNOLOGIC RESEARCH
- Directed Engineering of a High-expression Chimeric Transgene as a Strategy for Gene Therapy of Hemophilia A
- (2009) Christopher B Doering et al. MOLECULAR THERAPY
- Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
- (2009) Nichole L. Bryant et al. NEURO-ONCOLOGY
- Combined modality immunotherapy and chemotherapy: a new perspective
- (2008) Rupal Ramakrishnan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- NKG2D ligands: key targets of the immune response
- (2008) Segundo González et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started